-
April 21: The Week in Cancer NewsAwareness of HPV link to cancer has declined, and more frequent COVID-19 boosters authorized for people who are immunocompromised.
by Eric Fitzsimmons
-
Nudging Our Way to Better Cancer CareResearchers use insights from behavioral economics to encourage taking recommended actions in health care.
by Kevin McLaughlin
-
Post-surgery Option for Liver CancerNew study finds drug combination after surgery helps prevent recurrence in liver cancer patients.
by Thomas Celona
-
Chronic Stress and CancerAccumulating research shows lifelong stressors degrade health and increase cancer risk, but exercise might help counteract the impact of stress.
by Thomas Celona
-
Forward Look
Progress in Personalized Cancer VaccinesStudy finds mRNA vaccine can help prevent cancer recurrence in advanced melanoma patients.
by Thomas Celona
-
April 14: The Week in Cancer NewsTreatment vaccines are on the horizon, and immunotherapy drugs are effective in treating multiple myeloma.
by Kevin McLaughlin
-
Preventable Emergency Department Visits Trending Upwards for Patients with CancerAttentive care can manage conditions that cause patients to seek emergency care, but patients with concerning symptoms should still go to the hospital or urgent care center.
by Sandra Gordon
-
April 7: The Week in Cancer NewsNew therapy approved for locally advanced or metastatic bladder cancer, and court ruling could lead to cost hikes for certain cancer screenings.
by Thomas Celona
-
Most Cancer Doctors, Patients Interested in Integrative CareA nationwide survey found strong support for complementary therapies like massage and meditation, but also significant barriers to access.
by Kyle Bagenstose
-
March 31: The Week in Cancer NewsImmunotherapies poised to change care in advanced endometrial cancer, and the end of pandemic protection expected to result in loss of health coverage for 15 million people.
by Eric Fitzsimmons
A monoclonal antibody drug reduced the risk of smoldering myeloma progressing to multiple myeloma in patients at high risk for disease progression.
by Sandra Gordon
Immunotherapy Improves Survival in Bladder CancerNew research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
-
AACR IO: Revolutionizing Treatment through ImmunotherapyThe AACR’s immuno-oncology meeting brings together the leading experts in immunotherapy to accelerate progress in cancer science and medicine.
-
A New Resource Provides a Sanctuary for Black TNBC PatientsThe Black TNBC Sanctuary was created to help Black women with triple-negative breast cancer get answers about their diagnosis and care.
Dr. Humberto M. Guiot: Targeting Pancreatic Cancer in a Community-Based Clinical Trial
